Published in Microvasc Res on January 04, 2010
Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior. Acta Biomater (2012) 1.22
Controlled proteolytic cleavage site presentation in biomimetic PEGDA hydrogels enhances neovascularization in vitro. Tissue Eng Part A (2012) 0.94
In vitro models of angiogenesis and vasculogenesis in fibrin gel. Exp Cell Res (2013) 0.93
MMP-sensitive PEG diacrylate hydrogels with spatial variations in matrix properties stimulate directional vascular sprout formation. PLoS One (2013) 0.92
Potential for imaging engineered tissues with X-ray phase contrast. Tissue Eng Part B Rev (2011) 0.89
Strategies for vascularization of polymer scaffolds. J Investig Med (2010) 0.88
Effect of prevascularization on in vivo vascularization of poly(propylene fumarate)/fibrin scaffolds. Biomaterials (2015) 0.85
Evaluation of physical and mechanical properties of porous poly (ethylene glycol)-co-(L-lactic acid) hydrogels during degradation. PLoS One (2013) 0.84
Angiogenic responses are enhanced in mechanically and microscopically characterized, microbial transglutaminase crosslinked collagen matrices with increased stiffness. Acta Biomater (2013) 0.83
Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study. Am J Clin Nutr (2014) 0.81
Engineering clinically relevant volumes of vascularized bone. J Cell Mol Med (2015) 0.79
A self-assembling peptide matrix used to control stiffness and binding site density supports the formation of microvascular networks in three dimensions. Acta Biomater (2013) 0.78
Controlling the mechanical properties of three-dimensional matrices via non-enzymatic collagen glycation. Organogenesis (2013) 0.77
Endothelial cell sensing, restructuring, and invasion in collagen hydrogel structures. Integr Biol (Camb) (2015) 0.76
Dynamic indocyanine green angiography measurements. J Biomed Opt (2012) 0.75
Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl Acad Sci U S A (2016) 0.75
The versatility of the anterolateral thigh flap. Plast Reconstr Surg (2009) 2.38
Timing of presentation of the first signs of vascular compromise dictates the salvage outcome of free flap transfers. Plast Reconstr Surg (2007) 2.28
Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema. Plast Reconstr Surg (2009) 2.25
Simultaneous endoscope-assisted contralateral breast augmentation with implants in patients undergoing postmastectomy breast reconstruction with abdominal flaps. Plast Reconstr Surg (2006) 2.18
Simultaneous scarless contralateral breast augmentation during unilateral breast reconstruction using bilateral differentially split DIEP flaps. Plast Reconstr Surg (2011) 2.14
Strategies for a successful corrective Asian blepharoplasty after previously failed revisions. Plast Reconstr Surg (2004) 1.74
Breast reconstruction using the entire transverse abdominal adipocutaneous flap based on unilateral superficial or deep inferior epigastric vessels. Plast Reconstr Surg (2006) 1.43
Is ovarian pregnancy a medical illness? Methotrexate treatment failure and rescue by laparoscopic removal. Taiwan J Obstet Gynecol (2008) 1.38
Remote real-time monitoring of free flaps via smartphone photography and 3G wireless Internet: a prospective study evidencing diagnostic accuracy. Microsurgery (2011) 1.36
Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-1. J Biomed Mater Res A (2010) 1.33
Imaging challenges in biomaterials and tissue engineering. Biomaterials (2013) 1.28
A novel approach to the treatment of lower extremity lymphedema by transferring a vascularized submental lymph node flap to the ankle. Gynecol Oncol (2012) 1.21
Combined anterolateral thigh flap and vascularized fibula osteoseptocutaneous flap in reconstruction of extensive composite mandibular defects. Plast Reconstr Surg (2002) 1.20
The role of pore size on vascularization and tissue remodeling in PEG hydrogels. Biomaterials (2011) 1.19
Sustained low levels of fibroblast growth factor-1 promote persistent microvascular network formation. Am J Surg (2006) 1.19
Full range physiological mass transport control in 3D tissue cultures. Lab Chip (2012) 1.18
The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Biomaterials (2010) 1.14
An extended diffraction-enhanced imaging method for implementing multiple-image radiography. Phys Med Biol (2007) 1.13
Technique and strategy in anterolateral thigh perforator flap surgery, based on an analysis of 15 complete and partial failures in 439 cases. Plast Reconstr Surg (2002) 1.12
Formation, architecture and polarity of female germline cyst in Xenopus. Dev Biol (2004) 1.10
Endothelial cell-matrix interactions in neovascularization. Tissue Eng Part B Rev (2008) 1.10
Breast cancer recurrence after immediate reconstruction: patterns and significance. Plast Reconstr Surg (2003) 1.09
Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration. Microvasc Res (2009) 1.09
Extraction and assembly of tissue-derived gels for cell culture and tissue engineering. Tissue Eng Part C Methods (2009) 1.09
Surgical strategies to salvage the venous compromised deep inferior epigastric perforator flap. Ann Plast Surg (2010) 1.08
Design of a bioartificial pancreas(+). J Investig Med (2010) 1.08
Reconstruction of the buccal mucosa following release for submucous fibrosis using two radial forearm flaps from a single donor site. J Plast Reconstr Aesthet Surg (2009) 1.07
Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization. J Surg Res (2009) 1.06
The use of ultrasonography in preoperative localization of digital glomus tumors. Plast Reconstr Surg (2003) 1.05
Two small flaps from one anterolateral thigh donor site for bilateral buccal mucosa reconstruction after release of submucous fibrosis and/or contracture. J Plast Reconstr Aesthet Surg (2009) 1.04
A microfluidic platform for generating large-scale nearly identical human microphysiological vascularized tissue arrays. Lab Chip (2013) 1.04
Characterization of type I collagen gels modified by glycation. Biomaterials (2008) 1.04
The temporal and spatial dynamics of microscale collagen scaffold remodeling by smooth muscle cells. Biomaterials (2009) 1.02
Pregnancy complicated with pulmonary edema due to hyperthyroidism. J Chin Med Assoc (2005) 1.02
Double free flaps in head and neck reconstruction. Clin Plast Surg (2005) 1.01
Generation of porous poly(ethylene glycol) hydrogels by salt leaching. Tissue Eng Part C Methods (2010) 1.01
Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. Oral Oncol (2006) 1.00
Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma. Laryngoscope (2013) 0.99
Chimeric flap in clinical use. Clin Plast Surg (2003) 0.97
The role of adipose protein derived hydrogels in adipogenesis. Biomaterials (2008) 0.96
Evaluating 3D-printed biomaterials as scaffolds for vascularized bone tissue engineering. Adv Mater (2014) 0.95
Customized reconstruction with the free anterolateral thigh perforator flap. Microsurgery (2008) 0.95
A strategic approach for tongue reconstruction to achieve predictable and improved functional and aesthetic outcomes. Plast Reconstr Surg (2010) 0.95
Comparison of the medial sural artery perforator flap with the radial forearm flap for head and neck reconstructions. Plast Reconstr Surg (2009) 0.94
An agent-based model for the investigation of neovascularization within porous scaffolds. Tissue Eng Part A (2011) 0.94
Nonsteroidal anti-inflammatory drugs for wounds: pain relief or excessive scar formation? Mediators Inflamm (2010) 0.94
Local delivery of a collagen-binding FGF-1 chimera to smooth muscle cells in collagen scaffolds for vascular tissue engineering. Biomaterials (2009) 0.94
Multilayered microcapsules for the sustained-release of angiogenic proteins from encapsulated cells. Am J Surg (2010) 0.93
Reconstruction of through-and-through cheek defects involving the oral commissure, using chimeric flaps from the thigh lateral femoral circumflex system. Plast Reconstr Surg (2002) 0.93
MMP-sensitive PEG diacrylate hydrogels with spatial variations in matrix properties stimulate directional vascular sprout formation. PLoS One (2013) 0.92
Superficial temporal vessels as a reserve recipient site for microvascular head and neck reconstruction in vessel-depleted neck. Ann Plast Surg (2009) 0.91
Three-dimensional modeling of angiogenesis in porous biomaterial scaffolds. Biomaterials (2013) 0.91
Quantification of vascular density using a semiautomated technique for immunostained specimens. Anal Quant Cytol Histol (2002) 0.91
Typical and atypical clinical presentation of uterine myomas. J Chin Med Assoc (2012) 0.91
Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM). Am J Surg (2004) 0.90
Potential for imaging engineered tissues with X-ray phase contrast. Tissue Eng Part B Rev (2011) 0.89
Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels. Ann Surg Oncol (2012) 0.88
Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. Maturitas (2008) 0.88
Ovine model for engineering bone segments. Tissue Eng (2005) 0.88
Selection of recipient vessels in double free-flap reconstruction of composite head and neck defects. Plast Reconstr Surg (2005) 0.88
Strategies for vascularization of polymer scaffolds. J Investig Med (2010) 0.88
Deep inferior epigastric perforator flap for successful simultaneous breast and chest wall reconstruction in a Poland anomaly patient. Ann Plast Surg (2005) 0.87
The efficacy of acupoint stimulation for the management of therapy-related adverse events in patients with breast cancer: a systematic review. Breast Cancer Res Treat (2009) 0.87
Clinical significance of preoperative squamous cell carcinoma antigen in oral-cavity squamous cell carcinoma. Laryngoscope (2011) 0.87
Nondestructive volumetric imaging of tissue microstructure with benchtop x-ray phase-contrast tomography and critical point drying. Biomed Opt Express (2012) 0.87
A Prospective Evaluation of Lymphedema-Specific Quality-of-Life Outcomes Following Vascularized Lymph Node Transfer. Ann Surg Oncol (2014) 0.87
The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene. Taiwan J Obstet Gynecol (2008) 0.86
Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study. Oncol Rep (2008) 0.86
Effect of biomaterial properties on bone healing in a rabbit tooth extraction socket model. J Biomed Mater Res A (2004) 0.86
Simultaneous left maxillary and right mandibular reconstructions with a split osteomyocutaneous peroneal artery-based combined flap. Head Neck (2011) 0.86
Stability of alginate microbead properties in vitro. J Mater Sci Mater Med (2012) 0.86
Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen. Biomaterials (2007) 0.86
Anatomical basis and versatile application of the free medial sural artery perforator flap for head and neck reconstruction. Plast Reconstr Surg (2010) 0.85
The mechanism of vascularized lymph node transfer for lymphedema: natural lymphaticovenous drainage. Plast Reconstr Surg (2014) 0.85
Microvascular free tissue transfer for treatment of osteoradionecrosis of the maxilla. Plast Reconstr Surg (2005) 0.85
Fibrin-loaded porous poly(ethylene glycol) hydrogels as scaffold materials for vascularized tissue formation. Tissue Eng Part A (2012) 0.84
Materials for engineering vascularized adipose tissue. J Tissue Viability (2009) 0.84
The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function. Biomaterials (2011) 0.84
Evaluation of physical and mechanical properties of porous poly (ethylene glycol)-co-(L-lactic acid) hydrogels during degradation. PLoS One (2013) 0.84